PicconiFDi FlavianiAMalandruccoIGiordaniILongoSFrontoniS. The need for identifying standardized indices for measuring glucose variability. J Diabetes Sci Technol.2012;6 (1): 218–9.
2.
SiegelaarSEBarwariTKulikWHoekstraJBDeVriesJH. No relevant relationship between glucose variability and oxidative stress in well-regulated type 2 diabetes patients. J Diabetes Sci Technol.2011;5 (1): 86–92.
3.
SiegelaarSEHollemanFHoekstraJBDeVriesJH. Glucose variability; does it matter?. Endocr Rev.2010;31 (2): 171–82.
4.
SiegelaarSEKerrLJacoberSJDeVriesJH. A decrease in glucose variability does not reduce cardiovascular event rates in type 2 diabetic patients after acute myocardial infarction: A reanalysis of the HEART2D study. Diabetes Care.2011;34 (4): 855–7.
5.
HermanidesJVriesendorpTMBosmanRJZandstraDFHoekstraJBDeVriesJH. Glucose variability is associated with intensive care unit mortality. Crit Care Med.2010;38 (3): 838–42.
6.
MonnierLColetteCMasEMichelFCristolJPBoegnerCOwensDR. Regulation of oxidative stress by glycaemic control: Evidence for an independent inhibitory effect of insulin therapy. Diabetologia.2010;53 (3): 562–71.
7.
MonnierLMasEGinetCMichelFVillonLCristolJPColetteC. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA.2006;295 (14): 1681–7.
